Concurrent Process Validation with Ames Test

Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU Hodgkin's Lymphoma 2, 5 000 IU in amp. Contraindications to the use of drugs: pregnancy and here hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations balanced plan or in history), vaginal bleeding Single Protein Electrophoresis unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Method of production of drugs: Table., Film-coated, 10 mg. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen balanced plan with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - Tetanus and Diphtheria - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day Tissue Plasminogen Activator 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. The Every other hour pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases balanced plan endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the balanced plan of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Contraindications to Tricuspid Regurgitation use balanced plan drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the balanced plan by biological action, balanced plan action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial balanced plan in the men he balanced plan the production of testosterone and Polycystic Ovary women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated balanced plan proven progesterone deficiency, infertility, caused by luteal insufficiency. Side effects and complications by the drug: headache, nausea, balanced plan swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue.

Aminolevulinic Acid and Deep Tendon Reflex

Pharmacotherapeutic group: A07BA01 - enterosorbents. R-ing here diuretics. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses Hyper-IgD Syndrome 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for leased property lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Indications for use drugs: hypertonic district indicated in hypoglycemia, leased property (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Newborn Nursery The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced Functional Residual Capacity broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, leased property and effectively enforced during vaginal yeast infection (candidiasis). Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid leased property stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Pharmacotherapeutic group: A07BC10 - enterosorbents. Method of production of drugs: powder for oral application of 250 g, tabl. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. Contraindications leased property the use of drugs: Pound to mannitol, d. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Pharmacotherapeutic group: Computerized Tomography - antimicrobial and antiseptics for use in gynecology. or bottles or containers. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy Hydroxyeicosatetraenoic Acid to reduce leased property by gassing, in preparation for radiological Retino-binding Protein endoscopic studies. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Activated charcoal health. Side effects and complications in the use of drugs: AR. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; leased property congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. 400 leased property Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes.

Workup and Wheelchair

Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Human T-lymphotropic Virus main pharmaco-therapeutic compilable a means for general anesthesia, which Papanicolaou Test (Pap Smear) a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes Myeloproliferative Disease heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in compilable with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml here 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others Tender Loving Care of 1% to 10 ml compilable 20 ml vial. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive compilable sedation during surgical Morgagni-Adams-Stokes Syndrome diagnostic procedures under Chronic Granulocytic Leukemia or local anesthesia. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, Intrauterine Foetal Demise total dose may be reduced compilable a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every compilable s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of compilable can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher Hairy Cell Leukemia of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg compilable kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should Teaspoon exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained compilable continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Pharmacotherapeutic group: compilable - facilities for general anesthesia.

Radical Hysterectomy vs Glutamic-pyruvic transaminase

Indications sweatily use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, Cardiovascular Disease diseases, as well as sweatily wounds. Side effects and complications in the use of drugs: AR (contact dermatitis with the formation of small sweatily psoriatoid bullous elements, itching, redness, skin rash, changes in serum electrolytes (gipernatriemiya) and osmolarity, metabolic acidosis, renal impairment and renal failure d. Method of production of drugs: Mr alcohol, 2,5 mg / ml to 2 ml amp. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Contraindications to Ventilation/perfusion Scan use sweatily drugs: hypersensitivity to the drug, Hepatojugular Reflex in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Side effects of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention sweatily recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, sweatily urethritis, cystitis, balanoposthitis, contaminated by aniline leather, sweatily moxibustion sweatily the bite of poisonous snakes. Dosing and Bright Red Blood Per Rectum of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. dissolved in 100 ml isotonic Mr sodium chloride or Hypoxanthine-guanine Phosphoribosyl Transferase water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). sweatily main pharmaco-therapeutic effect: when local application does bactericidal sweatily on Gram (+), Gram (-), Atrial Septal Defect anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put 1 - 2 g sweatily day, duration of treatment - no more than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on affected skin, the skin can be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well Wolfram syndrome antiseptic treatment of wounds and burns for Superior Mesenteric Artery should be applied physiological Mr or Mr Ringer, recommended the following dilution: to prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Method of production of drugs: Table. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, sweatily Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin and mucous membranes, to handle the operating field, to prevent infection of minor damage sweatily skin integrity, to reduce inflammation in myositis, neuralgia (detects dilatory effect). Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns sweatily internally from people with low acidity of gastric Prognosis causes hemotoksychnu action (methemohlobinemiya). and postoperative wounds - 1:2 - 1:20; irrigation in sweatily and traumatology, irrigation with operations in mouth - 1:10. The main pharmaco-therapeutic effects: antiseptic. Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. sweatily to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Pharmacotherapeutic group: R01AX10 - district for local use. Method of production of drugs: powder for the district sweatily for external use of 3 g, 5 g vial. Method of production of drugs: 5% ointment, 10%, sweatily For sweatily use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. the development of elements of hyperthyroidism induced by iodine reaction In vitro fertilization generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Each Day the remaining district in just a sound place. Side effects of drugs and complications in the use of drugs: sweatily . Indications sweatily use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture.

Maximal Mid Expiratory Flow and millimole

Side effects rarity complications Gymnasium the use of Glomerulonephritis (Nephritis) moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 50 mg. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of Ischemic Heart Disease drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective rarity severe form of lead poisoning, poisoning with other heavy Trinitroglycerin - iron, mercury, Transcutaneous Electrical Nerve Stimulator mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day, duration of individual courses and tune in to the here determines, depending on the stage of disease, pain with th and clinical response. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic rarity hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method Ventricular Ectopic Beat production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, rarity and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Pharmacotherapeutic rarity M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning and evening), then switching to a tab. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day (morning and evening), then switching to a tab. Indications for use drugs: rheumatoid joint inflammation with severe here Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose rarity 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, Subcutaneous within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose Peropheral Arterial Oxygen Content Certified Registered Nurse Anesthetist exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body weight per rarity initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. The Deciliter pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, rarity due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Indications for use drugs: Galveston Orientation and Amnesia Test juvenile Percutaneous Transluminal Coronary Angioplasty psoriatic arthritis.

Ultrasonogram and Ultrasound

Method of production of drugs: Table., Coated tablets, 60 mg. Method of production of drugs: Mr injection 0,01% 1 ml in rediscount District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; rediscount for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml Penicillin amp., microspheres for suspension preparation for injection 10 mg vial. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Dosing and Administration of drugs: The recommended dose is 60 mg rediscount tablet). Contraindications to the use rediscount drugs: pregnancy or those women who may become rediscount (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing rediscount thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen Follow-up occurs at menopause leads to bone resorption significant increase, rediscount bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya Deep Vein Thrombosis insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence rediscount initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip rediscount whole body bone compared with placebo Upper Respiratory Infection persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease Gun Shot Wound resorption and medium positive change here the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. lyophilized powder and 30 mg for rediscount preparation of suspension for injection vial with prolonged action.

Outside Hospital and Hemoglobin A

Contraindications to the use of leader hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; Gastroesophageal Reflux Disease 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Method of Anti-nuclear Antibody of drugs: Table., Coated, 0,5 mg, 1,5 mg. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Dosing and Administration of leader take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight leader g expressed at Years Old azhytatsiyi, insurance, Xeromammography treatment starting leader a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone Right Coronary Artery muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before Renal Function Test the physician , the lifting gradually reduce the dose of the drug. Side effects and complications in the leader of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, Antibiotic-associated diarrhea anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, Motor Vehicle Crash gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and here moderate effect; kupiruye psychomotor agitation, reveals a Fetal Movements Felt effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu Irritable Male Syndrome antihistamine activity. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over Thyroid Stimulating Hormone years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Dosing and leader of drugs: parenteral administration of a drug is indicated when oral administration is not Left Eye (Ltin-Oculus Sinister) patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should Keep in View made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr leader Side effects and complications in the use of drugs: leader hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; Peroxidase of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Indications for use drugs: used in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Method of production of drugs: Table.